Platform establishment of integrative Chinese-Western medical treatment for cancer patients

Not Applicable

Active, not recruiting

• Conditions: cancer; Cancer - Any cancer; Public Health - Health service research

• Registration Number: ACTRN12613000211763
• Lead Sponsor: Committee on Chinese Medicine and Pharmacy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

From 2012 in May to 2012 in December, the Taipei Veterans General Hospital in the treatment of cancer patients, regardless of what kind of cancer, regardless of number of installments (stage 0, 1, 2, 3, 4), the age of twenty to eighty years old, take the initiative to the integration of cancer of Chinese and Western medical outpatient or to the TCM special clinic for cancer, requires the use of traditional Chinese medicine in patients.

Exclusion Criteria

Pregnant women, chronic liver disease (Bilirubin> 2 mg / dl), chronic kidney disease (Creatinine> 2 mg / dl), acute myocardial infarction patients, patients with the device pacemaker , non-cancer patients, terminal cancer combined heart and lung failure patients, postoperative psychiatric diagnoses were depression patients and cases do not want to sign a consent form.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Female-related hormone in serum[At baseline and at 1, 6, and 12 months]

Secondary Outcome Measures

Name	Time	Method
Medical outcomes study Short-form-12 health survey(MOS sf-12)[At baseline and at 1, 6 and 12 months]